Tvardi Therapeutics (TVRD) Stock Chart & Stock Price History $30.27 -0.32 (-1.05%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Tvardi Therapeutics Stock Price Performance The Tvardi Therapeutics (TVRD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 21.71%, reflecting recent market activity. As of the latest close, Tvardi Therapeutics traded at $30.59 with a market cap of $286.93 million and volume of 34,182 shares. Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+7.91%1 Month Performance+21.71%3 Month Performance-1.91% TVRD Stock Chart for Thursday, August, 28, 2025 TVRD Chart by TradingView Tvardi Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$30.59$30.27-1.05%$31.54$29.0721,349 shs$283.93 million08/27/2025$29.21$30.59+4.72%$30.79$28.8834,182 shs$286.93 million08/26/2025$29.20$29.21+0.03%$29.68$28.1316,769 shs$273.90 million08/25/2025$28.05$29.20+4.10%$29.93$27.5227,250 shs$273.90 million08/22/2025$26.65$28.05+5.25%$29.00$26.7442,712 shs$263.11 million08/21/2025$26.88$26.65-0.86%$27.20$25.5426,391 shs$249.98 million08/20/2025$24.67$26.88+8.96%$27.25$25.2216,604 shs$252.13 million08/19/2025$24.74$24.67-0.28%$25.60$24.0817,572 shs$230.91 million08/18/2025$24.00$24.74+3.08%$25.34$23.7910,712 shs$231.57 million08/15/2025$23.79$24.00+0.88%$24.62$23.7912,588 shs$224.64 million Get the Latest News and Ratings for TVRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$23.74$23.79+0.21%$24.05$22.9111,668 shs$222.67 million08/13/2025$23.60$23.74+0.59%$24.55$23.7017,500 shs$222.23 million08/12/2025$24.13$23.60-2.20%$25.00$23.4622,159 shs$220.90 million08/11/2025$23.92$24.13+0.88%$24.75$22.7432,952 shs$225.86 million08/08/2025$23.12$23.92+3.46%$24.89$22.4014,114 shs$223.89 million08/07/2025$24.14$23.12-4.23%$24.34$22.8413,990 shs$216.43 million08/06/2025$25.99$24.14-7.12%$25.49$23.7822,564 shs$225.95 million08/05/2025$26.34$25.99-1.33%$26.69$24.8844,015 shs$243.27 million08/04/2025$26.20$26.34+0.53%$27.76$25.4636,147 shs$246.57 million08/01/2025$25.96$26.20+0.92%$26.45$25.2722,180 shs$245.26 million07/31/2025$25.69$25.96+1.05%$26.55$25.6131,876 shs$242.99 million07/30/2025$25.98$25.69-1.12%$27.05$25.1119,303 shs$240.46 million07/29/2025$24.87$25.98+4.46%$26.62$24.3047,779 shs$243.20 million07/28/2025$26.52$24.87-6.22%$26.31$24.8015,664 shs$232.78 million Related Companies Nuvation Bio Stock Price Chart Verve Therapeutics Stock Price Chart Valneva Stock Price Chart Cronos Group Stock Price Chart Praxis Precision Medicines Stock Price Chart Mineralys Therapeutics Stock Price Chart Upstream Bio Stock Price Chart Oric Pharmaceuticals Stock Price Chart atai Life Sciences Stock Price Chart Pharming Group Stock Price Chart Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVRD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tvardi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tvardi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access